LifeSpan Vision Ventures Invests in Matter Bio
Summary
NORWALK, Conn., Oct. 23, 2023 /PRNewswire/ -- LifeSpan Vision Ventures today announced an investment in Matter Bio, a longevity holding company focused on preserving genome integrity. Jordan B. Burton, Scientific Analyst at LifeSpan Vision Ventures, stated: "Our investment in Matter Bio furthers our mission of supporting companies dedicated to longevity and slowing the key drivers of aging. The companys business model brings academic expertise, efficiency, and scale to pursue the mission of quantifying and reversing DNA damage to prevent diseases of aging and increase healthy lifespan. Our mission is to support and accelerate the development of innovative therapies that extend healthspan, improve the quality of life for individuals as they age, and address age-related challenges. Through strategic partnerships and investments, we aim to shape a future where aging is met with vitality, resilience, and endless possibilities.For more information about LifeSpan Vision Ventures, please visit https://www.lifespanvisionventures.com/.